Anal Dilatation for Infants and Children With Constipation

Not Applicable

• Conditions: Constipation
• Interventions: Drug: Lactulose

• Registration Number: NCT02255747
• Lead Sponsor: Tongji Hospital

Brief Summary

This study is to evaluate the effect of anal dilation in infants and children with constipation.

Detailed Description

Not available

Study Timeline

• Status Verified: 2014-09
• Study Start: 2014-09
• Study First Submitted: 2014-09-28
• Study First Submitted QC: 2014-09-30
• Last Update Submitted: 2014-09-30
• Study First Posted: 2014-10-03
• Last Update Posted: 2014-10-03
• Primary Completion: 2016-08
• Study Completion: 2016-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Infants and Children With Constipation
2. Postoperative infants and children with Hirschsprung's disease
3. Good compliance

Exclusion Criteria

1. Infants and Children With Constipation
2. Poor compliance

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Oral Lactulose	Lactulose	-
anal dilatation	Lactulose	-

Primary Outcome Measures

Name	Time	Method
Daily stool times	two years

Secondary Outcome Measures

Name	Time	Method
The amplitude of intestinal peristalsis waves	two years
The frequency of intestinal peristalsis waves	two years

Trial Locations

Locations (1)

Tongji Hospital; 🇨🇳 Wuhan, Hubei, China